These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32024004)

  • 1. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
    Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.
    Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q
    Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens.
    Walters DM; Stokes JB; Adair SJ; Stelow EB; Borgman CA; Lowrey BT; Xin W; Blais EM; Lee JK; Papin JA; Parsons JT; Bauer TW
    PLoS One; 2013; 8(10):e77065. PubMed ID: 24204737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model.
    Niedergethmann M; Alves F; Neff JK; Heidrich B; Aramin N; Li L; Pilarsky C; Grützmann R; Allgayer H; Post S; Gretz N
    Br J Cancer; 2007 Nov; 97(10):1432-40. PubMed ID: 17940512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
    Knudsen ES; Balaji U; Mannakee B; Vail P; Eslinger C; Moxom C; Mansour J; Witkiewicz AK
    Gut; 2018 Mar; 67(3):508-520. PubMed ID: 28073890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
    Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
    FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
    PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDX-1: demonstration of oncogenic properties in pancreatic cancer.
    Liu SH; Patel S; Gingras MC; Nemunaitis J; Zhou G; Chen C; Li M; Fisher W; Gibbs R; Brunicardi FC
    Cancer; 2011 Feb; 117(4):723-33. PubMed ID: 20886630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
    Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets.
    Liu L; Wang S; Cen C; Peng S; Chen Y; Li X; Diao N; Li Q; Ma L; Han P
    Mol Med Rep; 2019 Aug; 20(2):1901-1914. PubMed ID: 31257501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells.
    Dimitrov-Markov S; Perales-Patón J; Bockorny B; Dopazo A; Muñoz M; Baños N; Bonilla V; Menendez C; Duran Y; Huang L; Perea S; Muthuswamy SK; Al-Shahrour F; Lopez-Casas PP; Hidalgo M
    Mol Cancer Ther; 2020 Aug; 19(8):1751-1760. PubMed ID: 32499301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of pancreatic cancer and stromal desmoplasia.
    Crnogorac-Jurcevic T; Efthimiou E; Capelli P; Blaveri E; Baron A; Terris B; Jones M; Tyson K; Bassi C; Scarpa A; Lemoine NR
    Oncogene; 2001 Nov; 20(50):7437-46. PubMed ID: 11704875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase type M2 contributes to the development of pancreatic ductal adenocarcinoma by regulating the production of metabolites and reactive oxygen species.
    Yokoyama M; Tanuma N; Shibuya R; Shiroki T; Abue M; Yamamoto K; Miura K; Yamaguchi K; Sato I; Tamai K; Satoh K
    Int J Oncol; 2018 Mar; 52(3):881-891. PubMed ID: 29393401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.
    Kalinina T; Güngör C; Thieltges S; Möller-Krull M; Penas EM; Wicklein D; Streichert T; Schumacher U; Kalinin V; Simon R; Otto B; Dierlamm J; Schwarzenbach H; Effenberger KE; Bockhorn M; Izbicki JR; Yekebas EF
    BMC Cancer; 2010 Jun; 10():295. PubMed ID: 20553613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
    He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
    Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA CUDR promotes malignant phenotypes in pancreatic ductal adenocarcinoma via activating AKT and ERK signaling pathways.
    Liang X; Qi M; Wu R; Liu A; Chen D; Tang L; Chen J; Hu X; Li W; Zhan L; Shao C
    Int J Oncol; 2018 Dec; 53(6):2671-2682. PubMed ID: 30272271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.